Biosimilars: A Tipping Point

December 14, 2016

With biosimilars, the U.S. healthcare industry has a remarkable opportunity to make lifesaving and disease-altering drugs more accessible and more affordable. Read more.

Previous File
Enterprise Resource Planning (ERP) Buying Guide
Enterprise Resource Planning (ERP) Buying Guide

Selecting the appropriate ERP solution to manage the financial aspects of your healthcare business is a for...

Next File
11 Principles for Hardwiring Labor Management
11 Principles for Hardwiring Labor Management